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]ME possible involvement of different effector
systems (nitric oxide synthase, guanylate cyclase,
-adrenergic and muscarinic cholinergic recep-
tors, cyclooxygenase and lipoxygenase, and
Na+,K+-ATPase) was evaluated in a histamine H3
receptor agonist-induced ((R)-methylhistamine,
(R)a-MeHA) endothelium-dependent rat aorta
relaxation assay. (R)a-MeHA (0.1nM-0.01raM)
relaxed endothelium-dependent rat aorta, with a
pD2 value of 8.22 + 0.06, compared with a pD2
value of 7.98 + 0.02 caused by histamine (50%
and 70% relaxation, respectively). The effect of
(R)-MeHA (0.1nM-0.01mM) was competitively
antagonized by thioperamide (1, 10 and 30riM)
(pA2 9.21 + 0.40; slope 1.03 + 0.35) but it was
unaffected by pyrilamine (100riM), ctmettdine
(IM), atropine (10M), propranolol (IM),
indomethacin (10M) or nordthydroguaiaretic
acid (0.1 raM). Inhibitors of nitric oxide synthase,
-A-monomethylae (L-NMMA, 10M) and
N-nitro-L-arginine methylester (L-NOARG, 10vM)
inhibited the relaxation effect of (R)-MeHA, by
approximately 52% and 70%, respectively). This
inhibitory effect of L-NMMA was partially
reversed by L-arginine (10M). Methylene blue
(10M) and ouabain (10M) inhibited relaxation
(R)-MeHA-induced by approximately 50% and
90%, respectively. The products of cyclooxy-
genase and lipoxygenase are not involved in
(R)-MeHA-induced endothelium-dependent rat
aorta relaxation nor are the muscarinic choliner-
gic and -adrenergic receptors. The results also
suggest the involvement of NO synthase, guany-
late cyclase and Na+,K+-ATPase in (R)-MeHA-
induced endothelium-dependent rat aorta relaxa-
tion.
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Introduction
Histamine is present in essentially all tissues
and it can stimulate all three classes of histamine
receptors. It is found in significant concentrations
in the blood and also in the vessel walls. It has
been known for several years that histamine
receptor subtypes vary in different, isolated vas-
cular tissues, depending upon the anatomic loca-
tion, species and physiological response. It is
known that two types of histamine receptors, H1
and H2, participate in vascular responses to his-
tamine.
2 Intravascular administration of histamine
elicits a concentration-dependent fall in blood
pressure in most species. Many studies have indi-
cated the involvement of histamine H and H2
receptors in this depressor response. The hista-
mine H1 and H2 receptor-mediated actions of
histamine on effector cells are linked with the
accumulation of cGMP, inositol phospholipids
and cAMP, respectively.
4-6 In different blood
vessels cGMP formation is activated by endothe-
lium-derived relaxing factor (EDRF)7 while cAMP
formation is stimulated by prostacyclin (PGI2).8’9
The histamine H3 receptors were found within
the central nervous system of the rat and the
human where they appear to be involved in the
feedback control of both histamine synthesis and
release of the level of histaminergic nerve
endings,m’l Furthermore, stimulation of hista-
mine H3 receptors has been shown to inhibit
adrenergic and cholinergic neurotransmission in
the peripheral autonomic nervous system.12’13
There is some controversy about whether hista-
mine H3 receptors are present on the sympa-
thetic nerve fibres innervating blood vessels.
2
Stimulation of histamine H3 receptors by specific
agonist mediated vascular relaxant effects is
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caused by mechanism(s) which are not clear at are the calculated final concentrations in the bath
present. In two isolated vessels, the rabbit middle solution. When potassium chloride was used as a
cerebral artery4’15 and guinea-pig aorta6 a spasmogen, the stated concentration exluded the
potent and selective histamine H3 agonist, (R)z- potassium chloride already present in Tyrode’s
methylhistamine ((R)z-MeHA), caused relaxation solution.
probably via stimulation of postsynaptic hista-
mine H3 receptors. These findings suggest that,
depending on the species and the experimental
model, several mechanisms (activation of pre-
and post-synaptic histamine H3 receptors or his-
tamine H3 receptor-independent mechanisms)
contribute to the overall effect of (R)z-MeHA on
cardiovascular function.17
In our previous report the existence of hista-
Data analysis: Responses are expressed as a per-
centage of the maximal relaxation induced by
papaverine (100%, 0.1 mM). The slope of the log
concentration-response curve, correlation coeffi-
cient (r), Emax (maximum response) and pA2
(-log molar concentrations of antagonist redu-
cing the agonist response by a factor of 2) values
were evaluated from concentration-response
mine H3 receptors on rat aorta endothelium was curves plotted for (R)ot-MeHA in the presence of
shown.
-8 The present study was therefore under- thioperarnide. For calculating these different
values the data are expressed as means 4- S.E.M.; taken to assess the possible role of histamine H3
receptors located on the rat aorta endothelium
and their interactions with other effector systems.
Materials and Methods
n refers to the number of experiments. Emax
values were compared using Student’s t-test, p
values less than 0.05 were considered to be sig-
nificant
Drugs: The following compounds were used:
Vascular preparations: Male Wistar rats weighing acetylcholine chloride (Sigma), phenylephrine
between 100 and 200g were stunned and the hydrochloride (Sigma), histamine dihy-
thoracic aorta was excised and dissected free of drochloride (Sigma), (R)z-methylhistamine
surrounding tissue. Ring segments (4mm) were (Research Biochemicals Incorporated), pyr-
prepared and fixed isometrically in a 20ml organ ilamine maleate (Sigma), cimetidine (Sigma),
bath containing Tyrode’s solution of the follow- thioperamide maleate (Research Biochemicals
ing composition (mM): NaCl, 136.9; KCl, 2.69; Incorporated), atropine sulphate (Sigma), pro-
CaCl2, 1.8; MgCl2, 1.05; NaHCO3, 11.9; pranolol hydrochloride (Sigma), t-Ng-mono
NaH2PO4, 0.42; and glucose 5.55, at 37C under methylarginine (L-NMMA, Research Biochemicals
a moderate tension of lg for 90 min (the .Incorporated), A-nitro-t-arginine methylester
optimal point of its length-tension curve as NOARG, Research Biochemicals Incorporated), L-
determined from the tension developed in arginine (Sigma), indomethacin (Sigma), nordihy-
response to potassium chloride 40mM) and droguaiaretic acid (NDHGA, Sigma), ouabain
gassed with 95% 02/5% COg. The preparations octahydrate (Serva), methylene blue (Sigma) and
were precontracted by phenylephrine (300nM). papaverin hydrochloride (Sigma). All solutions
In some preparations the endothelium was were kept on ice until use except thioperamide
removed mechanically by gentle and careful which was dissolved in dimethylsulphoxide (pre-
rubbing of the intimal surface with a stainless- vious experiments had shown that the solvents
steel wire (31-gauge diameter)in order to avoid used had no effects on the preparations) and
stretching and damaging the vascular smooth (R)z-MeHA which was diluted in water and
muscle cells. The presence of endothelium was stored as an aliquot (100tl) at -20C. Indo-
confirmed by using acetylcholine (300nM). The methacin was dissolved in an equimolar con-
failure of acetylcholine to induce relaxation of centration with NaaCO3.
preparations was taken as an indication of endo-
thelium removal. Results
Experimental procedure: After the equilibration The influence of endothelium on responses to
period, concentration-response curves were histamine and (R)a-MeHA: Histamine (0.1 nM-
obtained by cumulative addition of histamine 0.01mM) induced concentration-dependent
(0.1 riM-0.01 mM) or (R)a-MeHA (0.1 nM- relaxation of phenylephrine (300 nM)-pre-
0.01 mM) on precontracted preparations alone or contracted rat aorta with intact endothelium,
in the presence of pyrilamine (100riM), cimeti- reaching approximately 70% of the papaverine-
dine (lbtM) and thioperamide (lnM, 10riM, induced maximum relaxation (0.1mM)
30 riM) for (R)a-MeHA_ (pD). 7.98 _+ 0.02). Removal of the endothe-
All drugs were added directly to the bath in a lium abolished the relaxation to histamine.
volume of 1501 and the concentrations given The potent and selective histamine H agonist,








10 -9 -8 -7 -6 -5 -4
substance, log M
4 5 6 7 8 9 10
ThIoperamide. -log M
10 -9 -8 -7 -6 -5 -4
(R)=-MeHA, log M
FIG. 1. Concentration-response curves for histamine and (R)-
MeHA in rat aorta with intact endothelium ((R)-MeHA alone or
in the presence of pyrilamine or cimetidine). The data are
expressed as means (n=6) (S.E.M. are exluded from diagram for
clarity and do not exceed 15% of the mean value for each
point). A, (R)-MeHA; O, histamine; (C), pyrilamine (100 nM); ,
cimetidine (1 IM); /M endothelium denuded.
FIG. 2. Concentration-response curves for (R)-MeHA in rat aorta
with intact endothelium alone or in the presence of thioper-
amide. The data are expressed as means (n=6) (S.E.M. are
exluded from diagram for clarity and do not exceed 15% of the
mean value for each point). The intercept on the abscissa scale
gives the pA2 value; y= 1.04x+ 9.55, r-- 0.948,
pA2 9.21 -I- 0.40, slope 1.03 -t- 0.35, for thioperamide. A,
Control; (C), thioperamide, nM; [], thioperamide, 10nM; I-I,
thioperamide, 30 nM.
(R)z-MeHA (0.1 nM-0.01 mM) induced con-
centration-dependent relaxation of phenylephrine
(300nM)-precontracted rat aorta with intact
endothelium reaching approximately 50% of the
papaverine-induced maximum relaxation
(0.1 mM) (pD2 8.22 4- 0.06). Removal of the
endothelium abolished the relaxation to (R)z-
MeHA (Fig. 1).
Effects of pyrilamine, cimetidine and thiopera-
mide: Pyrilamine (100riM, I for H 0.8nM,
Iq for H2 5.2/J,M, Kd for H > 3 btM, see
Hill19) or cimetidine (1 IM, I for Ha 0.8 tM,
I for H 0.45mM, I for H 33/.tM, see
Hill19) did not influence (R)z-MeHA-induced
endothelium-dependent rat aorta relaxation
(Fig. 1).
When thioperamide (1 nM, 10 nM, 30nM, Iq
for H1 > 100 I.tM, I for H2 > 10/J,M, Kd for H3
4.3 nM, see Arrang et a/.11) was present the
concentration-response curve for (R)z-MeHA-
induced relaxation was shifted to the right
without a significant change of the Emax. Schild
plot analysis indicated that antagonism by this
compound was competitive. The slope for the
regression curve was 1.03 4-0.35 with a pA
value of 9.21 __. 0.40 (Fig. 2).
Effects of atropine, propranolol, indomethacin
and NDHGA_. Neither atropine (101.tM), propra-
nolol (1 I.tM), indomethacin (10 tM) nor NDHGA
(0.1 mM) significantly reduced (R)z-MeHA-
induced endothelium-dependent rat aorta relaxa-
tion (data not shown).
Inhibition by L-NMMA and L-NOARG: Both inhi-
bitors of NO synthase inhibited (R)z-MeHA-
induced endothelium-dependent relaxation in a
concentration-dependent manner and this effect
was maximal after incubation with 101.tM L-
NMMA or 101.tM L-NOARG (approximately 52%
and 70% inhibition, respectively). The addition of
t-arginine (101M) partly reversed L-NMMA-
induced inhibition of the response to (R)z-MeHA
(Fig. 3). Higher concentrations (> 10btM) of
both inhibitors induced no further reduction of
relaxation (not shown).
Inhibition by methylene blue and ouabain:
Methylene blue (101,M) inhibited the (R)z-
MeHA-induced endothelium-dependent rat aorta
relaxation (approximately 50% inhibition).
Higher concentrations (> 10M) of inhibitor
induced no further reduction of relaxation.
Ouabain (101.tM) inhibited the (R)z-MeHA-
induced endothelium-dependent relaxation
(approximately 90% inhibition) (Fig. 4). Higher
concentrations (> 10 btM) of inhibitor induced
no further reduction of relaxation.
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FIG. 3. Concentration-response curves for (R)-MeHA in rat aorta
with intact endothelium in the presence of L-NMMA, L-NMMA +
L-arginine or L-NOARG. The data are expressed as means (n=6)
(S.E.M. are exluded from diagram for clarity and do not exceed
15% of the mean value for each point). A, Control; (C), L-NMMA,
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FIG. 4. Concentration-response curves for (R)-MeHA in rat aorta
with intact endothelium in the presence of methylene blue or
ouabain. The data are expressed as means (n=6) (S.E.M. are
excluded from diagram for clarity and do not exceed 15% of the
mean value for each point). A, Control; (C), methylene blue,
10 IM; ,, ouabain, 10 IM.
Discussion
The novel histamine H3 receptors were identi-
fied as inhibitory presynaptic autoreceptors on
histamine-containing nerve terminals in the rat
brain cortex but they have since been shown to
inhibit the release of various neurotransmitters
both in the central and peripheral nervous
system.9 Recent articles provide,strong evidence
for the presence of histamine H3 receptors at dif-
ferent sites, including rabbit middle cerebral
1 15 artery endothelium, guinea-pig aorta,6
mesenteric artery,
12 rabbit saphenous artery,
2
21 22 guinea-pig myocardium, guinea-pig ileum,
23 24 guinea-pig lung andbronchiole, guinea-pig
intestine,
25 porcine small intestine, rabbit
gastric glands,27 human adenoidal mast cells,
28
and human and rhesus monkey brain.29 The
endothelium-dependent relaxation to histamine
(0.1 nM-0.01 mM) was competitively antagonized
by pyrilamine (1 nM, 7 nM, 10nM) with a pA2
value of 9.336 +_ 0.34 and a slope of
1.09 _+ 0.36.1 It was also competitively antag-
onized by thioperamide (lnM, 10nM, 30nM)
with a pA2 value of 9.31 4-0.16 and a slope of
0.94 ___
0.10, but it was unaffected by cimetidine
(1 tM).
is The results with both histamine and
pyrilamine suggest the presence of histamine H
receptors on rat aorta endothelium, which is in
agreement with results of other authors.-2
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Thioperamide antagonizes both histamine and
(R)a-MeHA-induced relaxations resulting in
about the same pA2 values (9.31 for histamine
and 9.21 for (R)cz-MeHA in present paper,
respectively). These pA2 values are close to that
(8.96) found for blockade of histamine H medi-
ated inhibition of [H]-histamine release in rat
brain slices. The pA2 value of the histamine H
antagonist thioperamide was very similar to its
values for various responses mediated by hista-
mine H3 receptors.
33 A major point is the finding
that histamine is more active than (R)ot-MeHA,
which makes it uncertain whether only histamine
H3 receptors are involved. There is a hetero-
genous population of histamine receptors, H
and H3, on rat aorta endothelium.s This is not
surprising although the known histamine vascular
effects in different biological species involve two
receptor systems, the histamine H and histamine
H2 receptors. New observations suggest that
histamine H3 receptors are also localized at the
postsynaptic level in rabbit middle cerebral artery
endothelium,4’15 guinea-pig aorta6 and in the
epithelial wall of guinea-pig bronchioles,23 and
act on the smooth muscle. The mechanism
underlying the inhibitow effect of histamine H3
receptor stimulation on neurotransmitter release
in central and peripheral tissues remains to be
established. However, comparison with other
receptor systems, known to have a similar effectHistamineH3 receptor coupling on rat aorta endothelium
on neurotransmitter release (e.g. adenosine A1 Mso, in guinea-pig airway smooth muscle hista-
receptor, opiate receptor and (x2 adrenoceptor) mine can activate nitric oxide synthase resulting
suggests a number of possibilities for the effec- in .the release of NO.47
tor systems linked to the histamine H3 receptor. In different blood vessels, cGMP formation is
The possibilities include inhibition of adenylate activated by EDRF,
7 while cAMP formation is sti-
cyclase activity, activation of K+ channels and mulated by PGI2.8’9 Particularly from experiments
inhibition of voltage-dependent Ca
).+ chan- with endothelial cells cultured in vitro several
nels.34’35 Studies in slices of guinea-pig hippo- classes of agonist have been demonstrated to
campus have shown that the histamine H3 interact with surface receptors leading to PGI)
agonist (R)z-MeHA is not able to inhibit dima- synthesis. These include proteins and peptides
prit-induced cAMP accumulation36 suggesting that (thrombin and bradykinin), amines (histamine at
histamine H3 receptors are not negatively linked H1 receptors), eicosanoids (leukotriene C4) and
to adenylate cyclase. It is known that (R)z-MeHA, purines (ATP and ADP).
48 (R)z-MeHA-induced
a potent and selective histamine H3 agonist, endothelium-dependent rabbit middle cerebral
induced endothelium-dependent relaxation of artery relaxation was partially reduced by tra-
high-K+ precontracted rabbit middle cerebral nylcypromine (an inhibitor of leukotriene synth-
artery. That relaxation was not affected by ]3- esis) and also inhibited by dexamethasone (an
adrenoceptors, muscarinic or dopamine receptor inhibitor of prostaglandin synthesis probably at
antagonists.
5 Our results with atropine and pro- the level of phospholopase A249) and indometha-
pranolol also showed that neither muscarinic cin (an inhibitor of PGI2 synthesis5) indicated
cholinergic receptors nor ]3-adrenoceptors were that a prostanoid (probably PGI)) could also be
involved in (R)a-MeHA-induced endothelium- involved in (R)z-MeHA-induced endothelium-
dependent rat aorta relaxation, dependent rabbit middle cerebral artery relaxa-
The identification of nitric oxide (NO) (or a tion.5 The implication of results with indometha-
compound containing the NO ligand) such as cin and NDHGA is that (R)z-MeHA does not
EDRF37’38 and the finding that I-NMMA or t- induce the release of the relaxing factors con-
NOARG are inhibitors of NO synthesis in vascular taining metabolites of arachidonic acid via
endothelium39’4 have emphasized the impor- cyclooxygenase (e.g. PGE, PGE2, PGI)) or via
tance of local control of vasomotor tone. Nitric lipoxygenase (leukotrienes) on rat aorta endo-
oxide enhances production of cGMP in vascular thelium.
smooth muscles through activation of soluble In many arteries, the release of EDRF by ace-
guanylate cyclase, which in turn activates. Ca)+- tylcholine (Ach) is accompanied by an endothe-
ATPase to reduce intracellular Ca
2+ concentra- lium-dependent hyperpolarization, while EDHF is
tion and induces muscle relaxation. It has been the possible mediator.5 The EDHF-induced
demonstrated that t-NAME (a competitive inhi- hyperpolarization is produced by an increased
bitor of NO synthesis41), specifically inhibits permeability of the membrane to K+ ions with
cGMP formation due to the activation of mus- no change in either cAMP or cGMP.52 It has also
carinic, histamine, bradykinin and neurotensin been concluded that the hyperpolarization resul-
receptors in mouse neuroblastoma N1E-115 ted from stimulation of Na+,K+-ATPase. It has
cells.42 In our experiments the inhibitory effects been observed that in rat aorta and rat main
of I-NMMA and I-NOARG on (R)z-MeHA-induced pulmonary artery ACh released two different sub-
endothelium-dependent rat aorta relaxation were stances from endothelium. On factor (EDRF) is
also observed, indicating that these substances responsible for vascular muscle relaxation while
inhibit NO formation by competing with t-argi- the other (EDHF) hyterpolarizes the muscle
nine for binding to NO synthase. The addition of membrane by opening6Rb-permeable K+ chan-
t-arginine partly reversed t-NMMA-induced inhibi- nels.5 However, ouabain (an inhibitor of the
tion of response. We also found that the inhibi- Na+,K+-ATPase) inhibited (R)0t-MeHA-induced
tory effect of L-NOARG was greater than that of L- endothelium-dependent rat aorta relaxation
NMMA (70% and 52%, respectively) which is in much more than t-NOARG (90% and 70% inhibi-
agreement with the observations of different tion, respectively). It means that in addition to
15 43 44 authors. Methylene blue (which blocks NO, some factor other than NO (e.g. EDHF)
guanylate cyclase45) prevented the increase in could participate in (R)z-MeHA-induced endothe-
cGMP and thus inhibited (R)z-MeHA-induced Bum-dependent rat aorta relaxation. Inhibition of
q.- + endothelium-dependent rat aorta relaxation, the Na ,K -ATPase by ouabain would shift the
The decrease with age in the dilator response membrane potential to a less negative level and
of rat thoracic aorta to histamine is due to a thus reduce or abolish any hyperpolarization
decreased cGMP production and to an age- associated with K+ channel opening.
46 dependent decrease in endothelium function. In conclusion, we suggest that the products of
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cyclooxygenase and lipoxygenase are not
involved in (R)cz-MeHA-induced endothelium-
dependent rat aorta relaxation in addition to
muscarinic cholinergic and [3-adrenergic recep-
tors. The results also suggest the involvement of
NO synthase, guanylate cyclase and Na+,K+-
ATPase in histamine H3 receptor agonist-induced
((R)0t-MeHA) endothelium-dependent rat aorta
relaxation.
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